Leading Financial Services Firm, Arqaam Capital

Arqaam Capital

Leading Financial Services Firm

Established in 2007 in the Cayman Islands and the Dubai International Financial Centre (DIFC), the Arqaam Group’s strategy was to participate in and benefit from the growth of capital markets and investments in the MENA region. Arqaam Group has grown significantly since then to five offices in four countries (the UAE, KSA, Egypt and Lebanon); and has become one of the biggest home-grown firms in the DIFC and a leading top two institutionally focused financial services firm in the Middle East region. Arqaam Group has a professional and experienced team and has invested in people, processes and technology to create a highly scalable platform. Arqaam Group combines international best practice and corporate governance with regional know-how and experience to bridge capital with opportunity. Arqaam Group acts for institutions, family offices and high net worths seeking risk diversification and higher returns. “Arqaam” has become a strong brand name, with a reputation for professionalism, award winning products and services, clients and connections.

Equity Bottom-Up

Pure Health Holding PJSC / Equity Bottom-Up

<ul><li>International business led by HHG and Circle Health cover for weakness at UAE Care (UPP implementation, regulatory tightening, March disruptions), driving 11% y/y Care revenue growth to AED 5.2bn.</li><li>Daman remains resilient with stable margins, underwriting discipline and early P&amp;C traction.</li><li>Key Q1 call takeaways- UAE Care softness due to accounting and seasonality rather than structural demand weakness.</li></ul>Content is external report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

International business led by HHG and Circle Health cover for weakness at UAE Care (UPP implementation, regulatory tightening, March disruptions), driving 11% y/y Care revenue growth to AED 5.2bn.Daman remains resilient with stable margins, underwriting discipline and early P&amp;C traction.Key Q1 call takeaways- UAE Care softness due to accounting and seasonality rather than structural demand weakness.Content is external report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

PureHealth Holding (BUY, TP AED 3.8) HHG and Circle Offset Temporary UAE Headwinds

<ul><li>PureHealth is set to deliver strong earnings momentum in 2026, with 21% top line growth fueling 21% group profit jump to c.AED 2.4bn, driven by CARE (c.73% of Group revenues; HHG c.13% of gross hospital revenues) and COVER, supported by mandatory insurance rollout in the Northern Emirates and P&amp;C expansion (c.3% of GWPs, rising to c.14% by FY 31e).</li><li>Group continues to target margin-accretive (EBITDA &gt;20%) international expansion complementing flagship UAE network, supported by prudent leverage (2.5x Net debt/EBITDA), following HHG consolidation (10% of Q4 25A revenues, 12% of EBITDA), with c.9% contribution to FY 26e revenues.</li><li>Maintain Buy at AED 4.7 TP (+110% vs. CMP), -1% vs. previous target on 27% y/y higher debt (mainly HHG’s). Group declares AED 600m in dividends in FY 25A, equivalent to a 30% payout ratio and c.2.4% DY.</li></ul>Content is external report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

PureHealth is set to deliver strong earnings momentum in 2026, with 21% top line growth fueling 21% group profit jump to c.AED 2.4bn, driven by CARE (c.73% of Group revenues; HHG c.13% of gross hospital revenues) and COVER, supported by mandatory insurance rollout in the Northern Emirates and P&amp;C expansion (c.3% of GWPs, rising to c.14% by FY 31e).Group continues to target margin-accretive (EBITDA &gt;20%) international expansion complementing flagship UAE network, supported by prudent leverage (2.5x Net debt/EBITDA), following HHG consolidation (10% of Q4 25A revenues, 12% of EBITDA), with c.9% contribution to FY 26e revenues.Maintain Buy at AED 4.7 TP (+110% vs. CMP), -1% vs. previous target on 27% y/y higher debt (mainly HHG’s). Group declares AED 600m in dividends in FY 25A, equivalent to a 30% payout ratio and c.2.4% DY.Content is external report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

PureHealth Holding (Buy, TP AED 4.7) Company Update: HHG Boosts Group EPS by 13...

United Arab Emirates

Pure Health LLC is an integrated health care solutions provider. The Company offers hospital management, laboratory services, and medical supplies. Pure Health operates a cross-category ecosystem that covers hospitals, clinics, diagnostics, insurance, pharmacies, health-tech, and procurement.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Pure Health Holding PJSC (PUREHEAL UH)

PureHealth Holding (BUY, TP AED 3.8) HHG and Circle Offset Temporary UAE Headwinds

International business led by HHG and Circle Health cover for weakness at UAE Care (UPP implementation, regulatory tightening, March disruptions),...

Arqaam Capital

PureHealth Holding (Buy, TP AED 4.7) Company Update: HHG Boosts Group EPS by 13...

Maintain Buy at AED 4.7 TP (+110% vs. CMP), -1% vs. previous target on 27% y/y higher debt (mainly HHG’s). Group declares AED 600m in dividends in...

Arqaam Capital

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)